Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +53.02%
#2 TENDIES TENDIES +44.99%
#3 Pons Pons +44.77%
#4 PondCoin PondCoin +40.49%
#5 Ocean Protocol Ocean Protocol +33.26%
#6 StonkBroker StonkBroker +31.48%
#7 Purr Purr +31.06%
#8 Magma Finance Magma Finance +30.28%
#9 Starpower Starpower +28.07%
#10 The Bitcoin Bull The Bitcoin Bull +27.67%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
Arterra Bioscience Arterra Bioscience

Arterra Bioscience

ARBS
Rank in Stocks #28981
Arterra Bioscience S.p.A. is a biotechnology company fundamentally driven by... Arterra Bioscience S.p.A. is a biotechnology company fundamentally driven by scientific research, concentrating on the discovery and development of a wide range of ingredients and nature-based solutions. The firm's activities encompass the creation of advanced technological frameworks, innovative extraction methodologies, and foundational raw materials, specifically tailored for the beauty, agricultural, and nutritional supplement sectors. Established in 2003, Arterra Bioscience S.p.A. is headquartered in Naples, Italy.
Share Price
$3.62
Market Cap
$23.57M
Change (1 day)
-0.97%
Change (1 year)
21.29%
Country
IT
Trade Arterra Bioscience (ARBS)

Category

Healthcare
P/E ratio for Arterra Bioscience (ARBS)
P/E ratio as of 2026 TTM: 0
According to Arterra Bioscience latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Arterra Bioscience from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.